Targeting and Depletion of Acute Myeloid Leukemia Blasts By MEN1112, a Novel Humanized Defucosylated Monoclonal Antibodies with Specificity for Bst1/CD157 Antigen
Adriano Venditti(University of Rome Tor Vergata), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Daniela Bellarosa(Menarini Group (Italy)), Roberto Arriga(University of Rome Tor Vergata), Luca Maurillo(University of Rome Tor Vergata), Stefano Manzini(University of Milan), Maria Ilaria Del Principe(University of Rome Tor Vergata), Andrea Coppola(University of Rome Tor Vergata), Cecilia Simonelli(Menarini Group (Italy)), Anna Aureli(Istituto di Farmacologia Traslazionale), Sergio Amadori(Polyclinic Medical Center), Monica Binaschi(Menarini Group (Italy)), Alessandro Bressan(Menarini Group (Italy)), Patrizia Palomba(University of Rome Tor Vergata), Francesco Buccisano(University of Rome Tor Vergata)
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k